Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection

Journal of the American Society of Nephrology

Volumn 25, Issue 10, 2014, Pages 2267-2277

  Loupy, Alexandre ^a,c   Lefaucheur, Carmen ^b,c   Vernerey, Dewi ^c,d   Chang, Jessica ^e   Hidalgo, Luis G ^e,f   Beuscart, Thibaut ^c   Verine, Jerome ^b   Aubert, Olivier ^c   Dubleumortier, Sébastien ^h   Van Huyen, Jean Paul Duong ^a,c,i   Jouven, Xavier ^c   Glotz, Denis ^b,c   Legendre, Christophe ^a,c   Halloran, Philip F ^e,g  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c INSERM   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY MEDIATED REJECTION; ANTIBODY MEDIATED REJECTION MOLECULAR SCORE; ARTICLE; ASSESSMENT OF HUMANS; COHORT ANALYSIS; GENE EXPRESSION; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MICROSCOPE; PRIORITY JOURNAL; STRATIFICATION; AGED; DISEASE COURSE; FEMALE; GENE EXPRESSION PROFILING; GRAFT REJECTION; IMMUNOLOGY; KIDNEY; KIDNEY TRANSPLANTATION; MALE; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRANSPLANTATION; VALIDATION STUDY;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TRANSPLANTS;

EID: 84921747692     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013111149     Document Type: Article

References (31)

1. Garcia GG, Harden P, Chapman J; World Kidney Day Steering Committee 2012: The global role of kidney transplantation. Lancet 379: e36-e38, 2012
2. Lefaucheur C, Loupy A, Vernerey D, Duong-Van-Huyen JP, Suberbielle C, Anglicheau D, Vérine J, Beuscart T, Nochy D, Bruneval P, Charron D, Delahousse M, Empana JP, Hill GS, Glotz D, Legendre C, Jouven X: Antibody-mediated vascular rejection of kidney allografts: A population-based study. Lancet 381: 313-319, 2013
3. Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, Kaplan B, Halloran PF: Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 9: 2520-2531, 2009
4. Gaston RS, Cecka JM, Kasiske BL, Fieberg AM, Leduc R, Cosio FC, Gourishankar S, Grande J, Halloran P, Hunsicker L, Mannon R, Rush D, Matas AJ: Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 90: 68-74, 2010
5. Nankivell BJ, Alexander SI: Rejection of the kidney allograft. N Engl J Med 363: 1451-1462, 2010
6. Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL: Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 365: 318-326, 2011
7. Hartmann S, Gerber B, Elling D, Heintze K, Reimer T: The 70-gene signature as prognostic factor for elderly women with hormone receptorpositive, HER2-negative breast cancer. Breast Care (Basel) 7: 19-24, 2012
8. Reed SD, Lyman GH: Cost effectiveness of gene expression profiling for early stage breast cancer: A decision-analytic model. Cancer 118: 6298-6299, 2012
9. Prat A, Parker JS, Fan C, Cheang MC, Miller LD, Bergh J, Chia SK, Bernard PS, Nielsen TO, Ellis MJ, Carey LA, Perou CM: Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen. Ann Oncol 23: 2866-2873, 2012
10. Reeve J, Sellarés J, Mengel M, Sis B, Skene A, Hidalgo L, de Freitas DG, Famulski KS, Halloran PF: Moleculardiagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant 13: 645-655, 2013
11. Halloran PF, Pereira AB, Chang J, Matas A, Picton M, De Freitas D, Bromberg J, Serón D, Sellarés J, Einecke G, Reeve J: Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: An international prospective study (INTERCOM). Am J Transplant 13: 2865-2874, 2013
12. Sellarés J, Reeve J, Loupy A, Mengel M, Sis B, Skene A, de Freitas DG, Kreepala C, Hidalgo LG, Famulski KS, Halloran PF:Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant 13: 971-983, 2013
13. Famulski KS, de Freitas DG, Kreepala C, Chang J, Sellares J, Sis B, Einecke G, Mengel M, Reeve J, Halloran PF: Molecular phenotypes of acute kidney injury in kidney transplants. J Am Soc Nephrol 23: 948-958, 2012
14. Archdeacon P, Chan M, Neuland C, Velidedeoglu E, Meyer J, Tracy L, Cavaille-Coll M, Bala S, Hernandez A, Albrecht R: Summary of FDA antibody-mediated rejection workshop. Am J Transplant 11: 896-906, 2011
15. Sellarés J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF: Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 12: 388-399, 2012
16. Pencina MJ, D'Agostino RB Sr., Steyerberg EW: Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30: 11-21, 2011
17. Lefaucheur C, Nochy D, Hill GS, Suberbielle-Boissel C, Antoine C, Charron D, Glotz D: Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 7: 832-841, 2007
18. Données Informatiques Validées en Transplantation (DIVAT): Available at: http://www.divat.fr/. Accessed April 15, 2012
19. Agence Biomédecine: Cristal. Available at: http://www.sipg.sante.fr/portail/. Accessed April 15, 2012
20. Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin WM 3rd, Bracamonte ER, Broecker V, Cosio F, Demetris AJ, Drachenberg C, Einecke G, Gloor J, Glotz D, Kraus E, Legendre C, Liapis H, Mannon RB, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Rodriguez ER, Seron D, Seshan S, Suthanthiran M, Wasowska BA, Zachary AA, Zeevi A: Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 10: 464-471, 2010
21. Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; the Banff Meeting Report Writing Committee: Banff 2013 meeting report: Inclusion of c4dnegative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14: 272-283, 2014
22. Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Cendales L, Demetris AJ, Drachenberg CB, Farver CF, Rodriguez ER, Wallace WD, Glotz D; Banff Meeting Report Writing Committee: Banff 2011 Meeting report: New concepts in antibody-mediated rejection. Am J Transplant 12: 563-570, 2012
23. Loupy A, Hill GS, Suberbielle C, Charron D, Anglicheau D, Zuber J, Timsit MO, Duong JP, Bruneval P, Vernerey D, Empana JP, Jouven X, Nochy D, Legendre CH: Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 11: 56-65, 2011
24. Lefaucheur C, Loupy A, Hill GS, Andrade J, Nochy D, Antoine C, Gautreau C, Charron D, Glotz D, Suberbielle-Boissel C: Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 21: 1398-1406, 2010
25. Mueller TF, Einecke G, Reeve J, Sis B, Mengel M, Jhangri GS, Bunnag S, Cruz J, Wishart D, Meng C, Broderick G, Kaplan B, Halloran PF: Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 7: 2712-2722, 2007
26. Hidalgo LG, Sis B, Sellares J, Campbell PM, Mengel M, Einecke G, Chang J, Halloran PF: NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: Evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 10: 1812-1822, 2010
27. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF: Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 9: 2312-2323, 2009
28. Ogawa K, Tanaka K, Ishii A, Nakamura Y, Kondo S, Sugamura K, Takano S, Nakamura M, Nagata K: A novel serum protein that is selectively produced by cytotoxic lymphocytes. J Immunol 166: 6404-6412, 2001
29. Hidalgo LG, Sellares J, Sis B, Mengel M, Chang J, Halloran PF: Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant 12: 1180-1191, 2012
30. Steyerberg EW: Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating, 1st Ed., New York, Springer Science + Business Media, LLC, 2009
31. Pencina MJ, D 'Agostino RB:Overall C as ameasure of discrimination in survival analysis: Model specific population value and confidence interval estimation. Stat Med 23: 2109-2123, 2004